Nitrosamines in Pharmaceuticals: What are your options as March 31, 2021 Approaches? Webinar
Full recording now available on-demand! On August 26, 2020, IPA hosted this complimentary live webinar sponsored by Neopharm Labs. Presentation Outline: What are Nitrosamine impurities? The Valsartan Issue FDA Recall History Current Regulatory Situation Analytical Strategies and Options Case Studies Presented by: Mathieu Fournier, Director, R&D and Scientific Affairs, Neopharm Labs. If you missed out the […]